Albuminuria

Albuminuria
Classification and external resources
ICD-10 R80
ICD-9-CM 791.0
MeSH D000419

Albuminuria is a pathological condition wherein the protein albumin is abnormally present in the urine. It is a type of proteinuria. Albumin is a major plasma protein (normally circulating in the blood); in healthy people, only trace amounts of it are present in urine, whereas larger amounts occur in the urine of patients with kidney disease. For a number of reasons, clinical terminology is changing to focus on albuminuria more than proteinuria.[1]

Symptoms

It is usually asymptomatic but whitish foam may appear in urine. Swelling of the ankles, hands, belly or the face may occur if losses of albumin are significant and produce low serum protein levels (nephrotic syndrome).

Measurement

The amount of protein being lost in the urine can be quantified by collecting the urine for 24 hours, measuring a sample of the pooled urine, and extrapolating to the volume collected.

Also a urine dipstick test for proteinuria can give a rough estimate of albuminuria. This is because albumin is by far the dominant plasma protein, and bromphenol blue the agent used in the dipstick is specific to albumin.

Causes

The kidneys normally do not filter large molecules into the urine, so albuminuria can be an indicator of damage to the kidneys or excessive salt intake. It can also occur in patients with long-standing diabetes, especially type 1 diabetes. Recent international guidelines (KDIGO 2012) reclassified chronic kidney disease (CKD) based on cause, glomerular filtration rate category, and albuminuria category (A1,A2,A3).[1]

Causes of albuminuria can be discriminated between by the amount of protein excreted.

Treatment

Though there is some evidence that dietary interventions (to lower red meat intake) can be helpful in lowering albuminuria levels,[6] there is currently no evidence that low protein interventions correlate to improvement in kidney function.[7] Among other measures, blood pressure control, specially with the use of inhibitors of the renin-angiotensin-system, are the most common used therapies to control albuminuria.

References

  1. 1 2 3 KDIGO (Kidney Disease Improving Global Outcomes (2013). "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease" (PDF). Kidney International Supplement. 3 (1): 1–150. Retrieved 5 February 2016.
  2. Page 291 in: Basic Skills in Interpreting Laboratory Data. ISBN 978-1-58528-180-0. Retrieved 23 May 2013.
  3. Person—microalbumin level (measured) at Australian Institute of Health and Welfare. 01/03/2005
  4. Justesen, T.; Petersen, J.; Ekbom, P.; Damm, P.; Mathiesen, E. (2006). "Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes". Diabetes Care. 29 (4): 924–925. doi:10.2337/diacare.29.04.06.dc06-1555. PMID 16567839.
  5. KDIGO 2012. "Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease" (PDF).
  6. de Mello, V. D. F. et al. "Withdrawal of red meat from the usual diet reduces albuminuria and improves serum fatty acid profile in type 2 diabetes patients with macroalbuminuria." American Journal of Clinical Nutrition 83.5 (2006): 1032.
  7. Pan Yu et al. "Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials." American Journal of Clinical Nutrition 88 (2008): 660-666.
Wikisource has the text of the 1911 Encyclopædia Britannica article Albuminuria.
This article is issued from Wikipedia - version of the 11/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.